ARCA BIOPHARMA INC. overview

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO PR Newswire NEW YORK, April 9, 2024 NEW YORK , April 9, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and is investigating ARCA Biopharma, Inc. (Nasdaq:...

Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka PR Newswire MILWAUKEE, April 3, 2024 MILWAUKEE , April 3, 2024 /PRNewswire/ -- Ademi LLP is investigating ARCA (NASDAQ: ABIO) for possible breaches of fiduciary duty and other violations of law in its transaction with Oruka . Click here to learn how to join the https://www.ademilaw.com/case/arca-biopharma-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost...

ARCA anticipates filing an IND for AB201 for COVID-19 in September 2020 and initiating Phase 2B clinical testing as early as Q4 2020 WESTMINSTER, CO / ACCESSWIRE / August 12, 2020 / ARCA biopharma, Inc. (NASDAQ:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced it has completed a pre- Investigational New Drug (IND) consultation with the U.S. Food and Drug Administration (FDA) under...

...

...

...

Thinking about buying stock in Arca Biopharma, Cronos Group, Nio Inc., Precipio, or Square? PR Newswire NEW YORK, May 2, 2019 NEW YORK , May 2, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ABIO, CRON, NIO, PRPO, and SQ. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ABIO:...

...